[Home]   [Full version]  

Researchers develop buckyballs to fight allergy

Jun 20 ,Nanotechnology


A research team has identified a new biological function for a soccer ball-shaped nanoparticle called a buckyball – the ability to block allergic response, setting the stage for the development of new therapies for allergy.

Allergic disease is the sixth leading cause of chronic disease in the United States, and while various treatments have been developed to control allergy, no cure has been found. These findings advance the emerging field of medicine known as nanoimmunology.

The researchers, from Virginia Commonwealth University and Luna Innovations Inc., a private, Roanoke, Va., research company, are the first to show that buckyballs are able to block allergic response in human cell culture experiments.

Buckyballs, or fullerenes, are nanoparticles containing 60 carbon atoms. Due to their unique structure, inertness and stability, researchers from a number of scientific fields have been investigating the tiny, hollow carbon cages to serve a variety of functions. In this study, researchers modified the buckyballs so that they were compatible with water. The new study findings were published online in the June 19 issue of the Journal of Immunology and will appear in the July 1 print issue of the journal.

“This discovery is exciting because it points to the possibility that these novel materials can one day lead to new therapies,” said Chris Kepley, Ph.D., M.B.A., assistant professor in the Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology at the VCU School of Medicine.

“Researchers in many fields are aware of the potential fullerenes have, however, we are the first to show they can turn off the allergic response and basic immune reactions,” he said.

According to Kepley, who is the principal author of the paper, the buckyballs are able to ‘interrupt’ the allergy/immune response by inhibiting a basic process in the cell that leads to the release of an allergic mediator. Essentially, the buckyballs are able to prevent mast cells from releasing histamine.

Mast cells are responsible for causing allergic response and are packed with granules containing histamine. They are present in nearly all tissues except blood. When mast cells are activated, inflammatory substances such as histamine, heparin and a number of cytokines are rapidly released into the tissues and blood, promoting an allergic response.

The researchers found that the unique structure of the buckyball enables it to bind to free radicals dramatically better than any anti-oxidant currently available, such as vitamin E. Free radicals are molecules that cause oxidative stress, which experts believe may be the basis of aging.

“The immune system both protects us and causes harm, so we are always interested in finding new pathways to help manage the harmful effects,” said Kepley.

Source: Virginia Commonwealth University

Related stories:

Physical and sexual abuse linked to asthma in Puerto Rican kids
Children who are physically or sexually abused are more than twice as likely to have asthma as their peers, according to a recent study of urban children in Puerto Rico. In fact, physical and sexual abuse was second only to maternal asthma in all the risk factors tested, including paternal asthma and indicators of socioeconomic status.
Stress, anxiety can make allergy attacks even more miserable and last longer
A new study here shows that even slight stress and anxiety can substantially worsen a person's allergic reaction to some routine allergens. Moreover, the added impact of stress and anxiety seem to linger, causing the second day of a stressed person's allergy attack to be much worse.
Multi-tasking molecule holds key to allergic reactions
As the summer approaches most of us rejoice, reach for the sunscreen and head outdoors. But an ever-growing number of people reach for tissue instead as pollen leaves eyes watering, noses running and spirits dwindling. Hay fever is just one of a host of hypersensitivity allergic diseases that cause suffering worldwide and others, such as severe reactions to bee stings or eating peanuts, can be more serious and even fatal.
Asthma and other allergies tied to absence of specialized cells
When it comes to allergies, both the problem and the solution are found within us. Our immune systems respond to foreign substances with an arsenal of cells. Some are programmed to "remember" invaders they've encountered in the past. Normally, anything previously identified as harmless is allowed to pass. Sometimes, however, the immune response goes awry, triggering an allergic reaction.
Researchers say popular fish contains potentially dangerous fatty acid combination
Farm-raised tilapia, one of the most highly consumed fish in America, has very low levels of beneficial omega-3 fatty acids and, perhaps worse, very high levels of omega-6 fatty acids, according to new research from Wake Forest University School of Medicine.
Ancient antibody molecule offers clues to how humans evolved allergies
Scientists funded by the Biotechnology and Biological Sciences Research Council have discovered how evolution may have lumbered humans with allergy problems. The team from the Randall Division of Cell & Molecular Biophysics, King's College London are working on a molecule vital to a chicken's immune system which represents the evolutionary ancestor of the human antibodies that cause allergic reactions.
Farm moms may help children beat allergies
Mothers exposed to farms, particularly to barns and farm milk, while pregnant confer protection from allergies on their newborns, according to a group of German researchers, who will present their findings at the American Thoracic Society’s 2008 International Conference in Toronto on Wednesday, May 21.
Personalized therapy for asthma and COPD could soon be here
Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

News discussion:

Nanotechnology news

[Home]   [Full version]